Fidelity Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$36.1M Sell
2022
Q4
$49.6M Buy
2022
Q3
$29.3M Sell
2022
Q2
$56.2M Buy
2022
Q1
$59.1M Buy
2021
Q4
$52.5M Buy
2020
Q4
Sell
2020
Q3
$44.8M Buy
2020
Q2
$28.3M Buy